{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-23-097100","form_type":"8-K","ticker":"JSPR","cik":"0001788028","company_name":"Jasper Therapeutics, Inc.","filed_at":"2023-12-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.454608+00:00","generated_at":"2026-06-07T09:57:14.200033+00:00","sec_items":["5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Jasper Therapeutics stockholders approve reverse stock split authorization up to 1-for-10","bullets":["Reverse split proposal approved with 91,108,798 votes for, 873,917 against, 32,292 abstentions.","Board may implement split at ratio between 1-for-3 and 1-for-10 at any time before Dec 15, 2024.","Adjournment proposal also approved but was not needed; 91,306,235 votes for, 669,886 against.","Approximately 82% of outstanding shares were represented at the Dec 15 special meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-23-097100","json":"https://secwatch.observer/filing/0001213900-23-097100.json","markdown":"https://secwatch.observer/filing/0001213900-23-097100.md","text":"https://secwatch.observer/filing/0001213900-23-097100.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1788028/000121390023097100/0001213900-23-097100-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1788028/000121390023097100/ea190382-8k_jasper.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-07T09:57:14.200033+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7039c014736205b31e892a8b8df38d26bc95efe5","claim":"Jasper Therapeutics, Inc. shareholders approved Approve an amendment to the Certificate of Incorporation to effect a reverse stock split within a range of 1-for-3 to 1-for-10 at the 2023-12-15 meeting.","evidence_excerpt":"On December 15, 2023, Jasper Therapeutics, Inc. (the “Company”) held a Special Meeting of Stockholders","evidence_source":"SEC 8-K Item 5.07","evidence_url":"https://www.sec.gov/Archives/edgar/data/1788028/000121390023097100/0001213900-23-097100-index.htm","confidence":0.9,"family_label":"Shareholder Votes","details":[{"label":"Proposal","value":"reverse split"},{"label":"Outcome","value":"passed"},{"label":"Meeting","value":"2023-12-15"}],"fact_type":"shareholder_vote"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}